Stockscreener 앱 받기
25.02
2.12%
0.52
전일 마감가:
$24.50
열려 있는:
$25.18
하루 거래량:
1.88M
Relative Volume:
1.59
시가총액:
$2.19B
수익:
$23.38M
순이익/손실:
$-155.22M
주가수익비율:
-11.42
EPS:
-2.19
순현금흐름:
$-134.36M
1주 성능:
+14.72%
1개월 성능:
+17.08%
6개월 성능:
+4.86%
1년 성능:
-40.98%
1일 변동 폭
$24.76
$26.15
1주일 범위
$21.50
$26.15
52주 변동 폭
$13.45
$44.42
Ideaya Biosciences Inc Stock (IDYA) Company Profile
명칭
Ideaya Biosciences Inc
전화
650-443-6209
주소
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
IDYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
25.02 | 2.15B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 개시 | TD Cowen | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-06-26 | 개시 | Wells Fargo | Overweight |
| 2024-11-18 | 개시 | Stephens | Overweight |
| 2024-11-05 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-08 | 개시 | Mizuho | Outperform |
| 2024-03-08 | 개시 | BTIG Research | Buy |
| 2023-08-08 | 개시 | SVB Securities | Outperform |
| 2023-05-24 | 개시 | Goldman | Buy |
| 2023-04-24 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-23 | 개시 | Berenberg | Buy |
| 2023-02-28 | 개시 | RBC Capital Mkts | Outperform |
| 2022-12-28 | 개시 | CapitalOne | Overweight |
| 2022-10-27 | 개시 | Citigroup | Buy |
| 2022-08-15 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2022-03-10 | 업그레이드 | Stifel | Hold → Buy |
| 2021-09-23 | 개시 | Stifel | Hold |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-03-11 | 개시 | Guggenheim | Buy |
| 2020-10-07 | 개시 | Wedbush | Outperform |
| 2020-09-01 | 개시 | Northland Capital | Outperform |
| 2020-07-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-06 | 개시 | H.C. Wainwright | Buy |
| 2020-03-13 | 개시 | ROTH Capital | Buy |
| 2019-10-17 | 개시 | Oppenheimer | Outperform |
| 2019-09-10 | 개시 | Robert W. Baird | Outperform |
| 2019-06-17 | 개시 | Citigroup | Buy |
| 2019-06-17 | 개시 | JP Morgan | Neutral |
| 2019-06-17 | 개시 | Jefferies | Buy |
모두보기
Ideaya Biosciences Inc 주식(IDYA)의 최신 뉴스
How volatile is IDEAYA Biosciences Inc. stock compared to the marketRetirement Planning Updates For Consistent Profits - jammulinksnews.com
Chart based analysis of IDEAYA Biosciences Inc. trendsFree Fast Gaining Stock Screener Report - Newser
Historical volatility pattern of IDEAYA Biosciences Inc. visualizedProven Trading System with Consistent Gains - Newser
Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionFree Price Action Based Buy Opportunity List - Newser
Can IDEAYA Biosciences Inc. rally from current levelsSwing Entry Insight With Forecast Accuracy - Newser
Analyzing net buyer seller activity in IDEAYA Biosciences Inc.Trade Flow Monitor with Volume Tracker - Newser
Evaluating IDEAYA Biosciences Inc. with trendline analysisDaily Pick Forecast with Entry Zones - Newser
What catalysts could drive IDEAYA Biosciences Inc. stock higher in 2025Unlock daily market insights for better decisions - jammulinksnews.com
What is the risk reward ratio of investing in IDEAYA Biosciences Inc. stockHigh-margin investment plays - jammulinksnews.com
Will IDEAYA Biosciences Inc. stock benefit from AI tech trendsFree AI-Powered Stock Predictions - metal.it
Should I hold or sell IDEAYA Biosciences Inc. stock in 2025Invest smarter with data-backed trading alerts - jammulinksnews.com
What drives IDEAYA Biosciences Inc. stock priceSignificant capital appreciation - PrintWeekIndia
TD Cowen Bullish on Ideaya’s (IDYA) Oncology Pipeline - MSN
IDEAYA Biosciences (NASDAQ:IDYA) Research Coverage Started at TD Cowen - Defense World
What analysts say about IDEAYA Biosciences Inc. stockTriple-digit profit margins - PrintWeekIndia
Is IDEAYA Biosciences Inc. a good long term investmentRecord-setting profit potential - PrintWeekIndia
What makes IDEAYA Biosciences Inc. stock price move sharplyFree Investing Community - Newser
IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma - The Malaysian Reserve
IDEAYA to present phase 2 data on uveal melanoma drug at ESMO - Investing.com Nigeria
IDEAYA to present phase 2 data on uveal melanoma drug at ESMO By Investing.com - Investing.com South Africa
IDEAYA Biosciences Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth Strategy - Nasdaq
IDEAYA Biosciences: Precision Oncology Pipeline and Synthetic Lethality Catalysts - AInvest
IDEAYA's First-in-Class Cancer Pipeline: Major Clinical Updates Coming at 10th Anniversary R&D Day - Stock Titan
Signaturefd LLC Increases Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC - The Malaysian Reserve
IDEAYA Biosciences Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com
Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025 - TipRanks
Breakthrough Lung Cancer Drug IDE849 Shows First Human Results: 70+ Patient Data Coming at WCLC 2025 - Stock Titan
Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
IDEAYA Biosciences: TD Cowen initiates coverage with Buy rating. - AInvest
Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences - TipRanks
TD Cowen initiates Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com Canada
TD Cowen Initiates Coverage of IDEAYA Biosciences (IDYA) with Buy Recommendation - MSN
IDEAYA Biosciences CEO Fireside Chat: Precision Medicine Updates at BTIG Conference - Stock Titan
Ideaya Biosciences Inc (IDYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
1.06%
자본화:
|
볼륨(24시간):